Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
Search results for "Bio"
SK Bioscience Launches Quadrivalent Meningococcal Vaccine 'MenQuadfi' in Korea
SK Bioscience announced on the 9th that it has launched the quadrivalent meningococcal conjugate vaccine 'MenQuadfi' in Korea in collaboration with...
Ligakem Bio Receives ADC Platform Technology Fees from Ono Pharmaceutical
Ligakem Bioscience announced on the 8th that it is set to receive milestone payments related to the development...
Next-Generation Precision Medicine for Cancer Treatment... Amgen Acquires UK Biotech for 1 Trillion Won
Global pharmaceutical company Amgen is acquiring a UK biotech for up to $840 million (approximately 1.
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial
Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the...
Kangstem Biotech, 'Skin Organoid Source Technology' Registered Patent in Japan
Kangstem Biotech's technology related to skin organoids has been granted a patent in Japan.
Bluebird, Phoenix, and... Who Will Be ABL Bio's Next Technology Export Partner?
After Bluebird and Phoenix, what kind of bird will be the next partner for ABL Bio? ABL Bio is scheduled to meet with...
Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals
Ligand Pharmaceuticals announced on the 5th that it has recruited Dr. Han Jin-hwan, formerly of Merck, as the head of...
Samsung Bioepis to Directly Sell Ophthalmic Drug Baivubiz in Europe
Samsung Bioepis announced on the 4th that it has recovered the European commercialization rights for the ophthalmic...
AI-Powered Blood Test Detects 90% of Colorectal Cancers in Korean Study
For many people, colorectal cancer screening feels daunting from the start. South Korea’s national cancer screening...